RecallDepth
Class III Ongoing

Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608

This recall is currently active, issued April 21, 2021. It was issued by Asclemed Usa Inc. Dba Enovachem Pharmaceuticals.

Company
Asclemed Usa Inc. Dba Enovachem Pharmaceuticals
Recall Initiated
March 19, 2021
Posted
April 21, 2021
Recall Number
D-0330-2021
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Torrance, CA, United States
Official Source
View on FDA website ↗

Reason for Recall

Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Distribution

Distributed to three physicians in the following states: CA, LA (Enovachem). DocRx distributed recalled product to one Distributor located in AL.

Lot / Code Info

Lot #: 20K0043P, Exp. 8/31/2022; 20L0026P, Exp. 9/30/2022

More recalls by Asclemed Usa Inc. Dba Enovachem Pharmaceuticals

View all recalls by this company →

Other recent Class III Drug recalls